“Concurrent EGFR and KRAS Mutations in Non-Small Cell Lung Cancer: Challenging the Paradigm of Linear Targeted Therapy”. Journal of Current Biomedical Reports 6, no. 2 (June 30, 2025): 45–46. Accessed June 13, 2026. https://jcbior.homes/index.php/JCBioR/article/view/299.